Expertise & Services

Expertise

The pathology core provides comprehensive, rapid molecular pathology services ranging from standard histology to custom work such as TMA construction, antibody validation, and genomic analysis including CISH and FISH, in addition to providing the pathology expertise required for scoring and interpretation of results.

Services

Our molecular pathology and applied genomics core is supported by a world class team of molecular pathologists and offers a broad range of analytical services to the public and private sectors including:

  • Immunohistochemistry (Single, Double, and Multiplex staining)
  • In situ immunofluorescence
  • In situ hybridization (FISH & CISH)
  • In situ Toxicology Analysis
  • In situ Proximity-ligation Analysis

Tissue Micro Array (TMA) construction

High-throughput scanning and Digital Image Analysis (Image storage service, Remote VPN access)

Whole Mount Tissue Analysis

Updated: April 9, 2021

 

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Pars for Prostate fundraiser: September 22, 2022

The First Annual Pars for Prostate golf fundraiser in support of Prostate Cancer Foundation BC takes place September 22, 2022 at Westwood Plateau Golf Course. For information and to register please visit www.parsforprostate.ca

Dr. Black

Terry Fox Run fundraiser: September 18th, 2022

The 42nd Annual Terry Fox Run is taking place on Sunday September 18, 2022. If you are able, please consider joining and/or donating to our team (tax receipts issued), raising funds for the Terry Fox Foundation's ground-breaking cancer research

Employment

Work at the Vancouver Prostate Centre

Tuesday, September 20, 2022

Dr Mads Daugaard develops an AI cell analytics app which could supercharge biotechnology research

Wednesday, July 20, 2022

With just a tablespoon of blood, B.C. researchers aim to transform cancer treatment